Anuh Pharma Gets Prequalification Nod from WHO for Anti-Malarial Bulk Drug
Anuh Pharma receives World Health Organization (WHO) prequalification for Amodiaquine Hydrochloride API, an essential anti-malarial medicine used in combination therapies for Plasmodium falciparum malaria.
Amodiaquine Hydrochloride API | 06/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy